Searched for
PHARMA OUTLOOK FOR 2025
Rs 1,100 crore a day nightmare: Why FIIs are ruthlessly selling bank stocksForeign investors are aggressively selling Indian bank stocks, offloading over ₹1,100 crore daily due to global economic pressures and port...- Reliance, financials and defence top investment picks as market leadership broadens: Rahul ShahReliance Industries is poised for a turnaround, with strong earnings, a Jio Platforms IPO, and AI/energy investments promising significant ...
- Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
- FIIs sell over Rs 30K crore worth of Indian equities in May as outflows swell to Rs 2.22 lakh crore. What lies ahead?FIIs have consistently sold Indian equities in 2026, totaling Rs 2.22 lakh crore due to global uncertainty, geopolitical tensions, elevated...
- JP Morgan warns of FY27 earnings risk, says Nifty can fall to 20,500 in bear caseJP Morgan has cautioned that India’s FY27 earnings face significant risks from an extended energy and logistics shock linked to the Middle ...
- Cohance Lifesciences shares slip 7% after Jefferies cuts target price, downgrades on weak Q4Cohance Lifesciences shares dropped significantly after reporting an 84% year-on-year decline in March-quarter net profit. Jefferies downgr...
- Markets likely near bottom range; stay invested: Devina MehraDevina Mehra of First Global believes Indian equity markets are in a bottoming zone, advising investors to stay invested. She anticipates 2...
- What war? Smallcap stocks defy Middle East tensions with up to 56% gains in 2 months as Nifty slidesDespite Middle East tensions and a sliding Nifty50, India's smallcap stocks have surged up to 56% in two months. While institutional desks ...
- F&O Talk: Nifty slips below 20 & 50EMA. Sudeep Shah's tips to ride monthly expiry, trade 6 big weekly moversIndian equities experienced a broad-based sell-off, with Nifty and Sensex closing significantly lower. IT stocks led the decline, while pha...
- Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...
- How Ashish Kacholia, Mukul Agrawal, Madhu Kela, Dolly Khanna reshuffled portfolios amid Iran war?Amid a sharp market sell-off triggered by Iran war tensions and rising oil prices, marquee investors like Ashish Kacholia, Mukul Agrawal, M...
- Sunil Singhania-backed Abakkus Flexi Cap Fund raises stake in HDFC Bank, RIL and 28 other stocks in MarchAbakkus Flexi Cap Fund, backed by Sunil Singhania, boosted its holdings in HDFC Bank and Reliance Industries in March. The fund also increa...
- Sudeep Pharma IPO Day 2: Subscribed over 2.5x, GMP rises. Should you apply?Sudeep Pharma’s Rs 895-crore IPO has seen strong early interest, already oversubscribed on Day 1 with robust demand from retail and NII inv...
- Pharma industry to outdo India Inc in 2025 pay hike: StudyPharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the previous year but sti...
- 3 equity mutual fund categories lose up to 7% in 2025. Expert shares what went wrongEquity mutual funds face losses this year. Technology, pharma, and small-cap funds are the top losers. Tata Digital India Fund saw the bigg...
- Stock Radar: Strides Pharma breaks out from 7-month consolidation to hit fresh 52-week high; time to buy?Strides Pharma Science stock shows positive movement. It broke a seven-month consolidation phase. Experts suggest a buy with a target of Rs...
- ETMarkets PMS Talk: Financials, Pharma, and Textiles: Top sector picks for 2025 by Prabhakar KudvaJanuary and February have seen a sharp correction in both the schemes in line with the broader markets. While the indices may not have fall...
- 2025 Outlook: Will pharma sector get a shot in its arm in 2025?Pharma 2025 Forecast: Pharma and healthcare mutual funds have topped with an average return of 38.05% in 2024. HDFC Pharma and Healthcare F...
- Year-ender 2024: Pharma takes pole position for 2025 race with 39% index returns, 9 multibaggers. Which stocks to buy?BSE Realty’s 35% returns are on the back of solid performances by stocks like Anant Raj, Sobha, Oberoi Realty, Prestige Estates and Godrej ...
- Bullish about Dr Reddy's Lab in the: KR ChokseyI am bullish on Dr. Reddy's because this company is having an edge over the other generic manufacturers.
Load More
